iSAM Funds UK Ltd Buys New Shares in Globe Life Inc. $GL

iSAM Funds UK Ltd bought a new position in Globe Life Inc. (NYSE:GL) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 12,932 shares of the company’s stock, valued at approximately $1,849,000.

A number of other institutional investors have also bought and sold shares of GL. Mather Group LLC. bought a new stake in Globe Life during the third quarter valued at about $28,000. CYBER HORNET ETFs LLC purchased a new position in shares of Globe Life in the second quarter valued at about $28,000. MUFG Securities EMEA plc bought a new position in shares of Globe Life in the second quarter worth about $31,000. Quent Capital LLC bought a new position in shares of Globe Life in the third quarter worth about $36,000. Finally, AlphaCore Capital LLC grew its position in shares of Globe Life by 1,557.1% during the second quarter. AlphaCore Capital LLC now owns 348 shares of the company’s stock worth $43,000 after purchasing an additional 327 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Trading Down 0.2%

Shares of NYSE GL opened at $138.51 on Friday. Globe Life Inc. has a 1-year low of $109.38 and a 1-year high of $152.71. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The business’s 50 day moving average is $142.07 and its two-hundred day moving average is $139.01. The stock has a market capitalization of $10.89 billion, a P/E ratio of 9.84 and a beta of 0.46.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). The company had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.30%. Globe Life’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same period in the previous year, the business earned $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, research analysts expect that Globe Life Inc. will post 13.87 EPS for the current year.

Globe Life Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.33 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a yield of 1.0%. Globe Life’s payout ratio is presently 7.67%.

Analysts Set New Price Targets

Several analysts recently issued reports on GL shares. TD Cowen reissued a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Wells Fargo & Company increased their price objective on shares of Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a report on Wednesday, February 25th. Piper Sandler reiterated an “overweight” rating and set a $167.00 price objective on shares of Globe Life in a research report on Friday, November 21st. JPMorgan Chase & Co. boosted their target price on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Finally, Truist Financial upped their target price on shares of Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $171.33.

Insider Activity at Globe Life

In other Globe Life news, CMO Jennifer Allison Haworth sold 10,000 shares of the business’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the transaction, the chief marketing officer owned 17,479 shares in the company, valued at $2,501,944.06. The trade was a 36.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO James Matthew Darden sold 18,318 shares of the stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $145.10, for a total transaction of $2,657,941.80. Following the completion of the sale, the chief executive officer directly owned 51,093 shares in the company, valued at approximately $7,413,594.30. This represents a 26.39% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 92,186 shares of company stock valued at $13,358,379 over the last three months. Corporate insiders own 1.51% of the company’s stock.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.